advertisement
Abstract #6771 Published in IGR 4-1
Drugs and closed-angle glaucoma risk
Pozzi D; Giraud C; Callanquin MJournal Français d'Ophtalmologie 2002; 25: 91-101
Closed-angle glaucoma presents in predisposed patients (narrow iridocorneal angle) in response to various stimuli. Most of the attacks are of iatrogenic origin: all topical and systemic mydriatic drugs can provoke an angle-closure glaucoma attack. Dangerous active ingredients in closed-angle glaucoma are substances with anticholinergic activity (peripheral action, central action, with anticholinergic side-effects), active ingredients with sympathomimetic alpha activity (α 1, α and β with indirect effects), and active ingredients with parasympathomimetic activity (anticholinesterases). Proprietary medicines, whether or not they are included in the French dictionary Vidal®, are classified according to their administration route and their different indications. The risk of closed-angle glaucoma after administration of these drugs is noted in the items' contraindications and precautions in the summary of the product characteristics included in the marketing authorization.LA: French
Dr. C. Giraud, Service de Pharmacie, Hopital Louis Mourier, 178, rue des Renouillers, 92701 Colombes Cedex, France
Classification:
9.3.1 Acute primary angle closure glaucoma (pupillary block) (Part of: 9 Clinical forms of glaucomas > 9.3 Primary angle closure glaucomas)
